ReviewMedicinal research reviews2026

Developing the Dopamine D3 Receptor (D3R) Antagonist, (R)-VK4-116, as a Non-Opioid Medication for the Treatment of Opioid Use Disorder.

Chia-Kuei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.